Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Paul Suhocki

Diagnostic Radiology Durham, NC Medical Doctor

NPI 1215023239 CMS profile 9291

4101 N Roxboro St, Durham, NC 27704

Open in the dashboard

General payments

$3,033

26 records reported · program years 2019–2025

Research payments

$351,640

Paid to them · 8 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$41,519 paid to institutions, not to them · program year 2021

Through program year 2025, Paul Suhocki of Durham, NC is reported in the CMS Open Payments database as having received $3,033 across 26 general payments and $351,640 in research payments paid to them. Separately, studies naming them as principal investigator received $41,519 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $300 3
2024 General $69 2
2023 General $543 7
2022 General $514 6
2021 General $117 1
2020 General $102 1
2020 Research $127,586 2
2019 General $1,387 6
2019 Research $224,054 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paul Suhocki
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Paul Suhocki were reported at $300. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Paul Suhocki Diagnostic Radiology median Middle half National median
2019 $1,387 $108 $29–$318 $163
2020 $102 $65 $21–$252 $114
2021 $117 $92 $24–$292 $132
2022 $514 $104 $29–$294 $149
2023 $543 $110 $29–$337 $160
2024 $69 $113 $30–$356 $164
2025 $300 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Philips Electronics North America Corporation $1,200 1 payment
  2. Boston Scientific Corporation $548 6 payments
  3. Bard Peripheral Vascular, Inc. $309 5 payments
  4. Medtronic, Inc. $186 2 payments
  5. Inari Medical, Inc. $172 1 payment
  6. Terumo Medical Corporation $156 4 payments
  7. Abbott Laboratories $136 2 payments
  8. W. L. Gore & Associates, Inc. $129 1 payment
  9. Medtronic Vascular, Inc. $102 1 payment
  10. Argon Medical Devices, Inc. $50 1 payment
  11. Other $44 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,833 25 payments
  2. Consulting Fee $1,200 1 payment
Products named General payments · program years 2019–2025
  1. CVX-300 $1,200 1 payment
  2. General - Embolics $212 2 payments
  3. Abre $186 2 payments
  4. FLOWTRIEVER CATHETER, S $172 1 payment
  5. CT THROMBECTOMY SYSTEM KIT $172 1 payment
  6. EMBOLD Fibered $169 2 payments
  7. Perclose ProGlide suture mediated closure system $136 2 payments
  8. VIATORR Endoprosthesis $129 1 payment
  9. General - Non-Vascular Intervention $128 1 payment
  10. Azur CX Detachable $119 2 payments
  11. Other $444 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Bausch Health US, LLC $351,640 8 payments

Billing to Medicare

Part B · data year 2024 · 109 billing codes

Paid by Medicare

$63,027

Of which drugs: $48

Medicare patients

212

Average age 68

Services billed

994

104 women, 108 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 58%
Diabetes 45%
Arthritis 40%
Ischemic heart disease 31%
Depression 31%
Cancer 30%
Heart failure 29%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, midazolam hydrochloride, per 1 mg J2250 Office 14 32 $4

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

34 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record